NASDAQ : TXMD
TherapeuticsMD, Inc. — Financial statements
Healthcare · Drug Manufacturers - Specialty & Generic · United States
Last price 1.83 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 21.18M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
TherapeuticsMD, Inc. (TXMD) reported revenue of 3.27M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 3.27M | 3.02M | 1.76M | 1.30M | 69.96M | 2.57M |
| Cost of Revenue | 1.40M | 1.40M | ||||
| Gross Profit | 3.27M | 3.02M | 1.76M | 1.30M | 68.57M | 1.17M |
| Selling, General & Admin | 4.64M | 5.00M | 4.74M | 8.90M | 56.71M | 72.75M |
| Operating Expenses | 5.02M | 5.39M | 5.25M | 9.82M | 57.90M | 72.75M |
| Operating Income | -1.75M | -2.37M | -3.49M | -8.52M | 10.66M | -71.58M |
| Interest & Investment Income | 193.00K | 142.00K | 135.00K | |||
| Other Non Operating Income (Expenses) | 1.40M | 1.75M | 2.28M | 781.00K | -117.00K | 272.00K |
| EBT Excluding Unusual Items | -162.00K | -477.00K | -1.07M | -7.74M | 10.55M | -71.31M |
| Merger & Restructuring Charges | -9.47M | |||||
| Asset Writedown | -101.00K | -176.00K | -1.27M | |||
| Other Unusual Items | -8.00M | |||||
| Pretax Income | -263.00K | -653.00K | -2.34M | -7.74M | 1.07M | -79.31M |
| Income Tax Expense | 32.00K | -31.00K | -43.00K | |||
| Earnings From Continuing Operations | -295.00K | -653.00K | -2.31M | -7.70M | 1.07M | -79.31M |
| Earnings From Discontinued Operations | 78.00K | 84.00K | 131.00K | -2.58M | 110.92M | -93.11M |
| Net Income | -217.00K | -569.00K | -2.18M | -10.28M | 112.00M | -172.41M |
| Net Income to Common | -217.00K | -569.00K | -2.18M | -10.28M | 112.00M | -172.41M |
| Shares Outstanding (Basic) | 11.57M | 11.57M | 11.53M | 10.44M | 9.03M | 7.96M |
| Shares Outstanding (Diluted) | 11.57M | 11.57M | 11.53M | 10.44M | 9.37M | 7.96M |
| EPS (Basic) | -0.02 | -0.05 | -0.19 | -0.98 | 12.41 | -21.66 |
| EPS (Diluted) | -0.02 | -0.05 | -0.19 | -0.99 | 11.95 | -21.66 |
| Free Cash Flow | 3.12M | 2.42M | 732.00K | -48.14M | -4.08M | -142.73M |
| Free Cash Flow Per Share | 0.27 | 0.21 | 0.06 | -4.61 | -0.43 | -17.93 |
| Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% | 98.00% | 45.51% |
| Operating Margin | -53.55% | -78.33% | -198.30% | -654.61% | 15.24% | -2,781.85% |
| Profit Margin | -6.64% | -18.83% | -123.85% | -789.40% | 160.08% | -6,700.93% |
| Free Cash Flow Margin | 95.41% | 80.21% | 41.57% | -3,697.46% | -5.83% | -5,547.10% |
| EBITDA | -1.37M | -1.98M | -2.98M | -8.08M | 11.86M | -70.84M |
| EBITDA Margin | -41.87% | -65.62% | -169.39% | 16.95% | ||
| D&A For EBITDA | 382.00K | 384.00K | 509.00K | 438.50K | 1.19M | 736.00K |
| EBIT | -1.75M | -2.37M | -3.49M | -8.52M | 10.66M | -71.58M |
| EBIT Margin | -53.55% | -78.33% | -198.30% | 15.24% | ||
| Revenue as Reported | 69.96M | 2.57M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 9.19M | 7.48M | 5.06M | 4.33M | 38.07M | 64.91M |
| Cash & Short-Term Investments | 9.19M | 7.48M | 5.06M | 4.33M | 38.07M | 64.91M |
| Accounts Receivable | 3.39M | 3.52M | 3.56M | 3.09M | ||
| Other Receivables | 682.00K | 672.00K | 539.00K | |||
| Receivables | 4.08M | 4.20M | 4.10M | 3.09M | ||
| Prepaid Expenses | 147.00K | 89.00K | 70.00K | 253.00K | 1.17M | 2.73M |
| Restricted Cash | 11.25M | |||||
| Other Current Assets | 2.71M | 2.68M | 3.03M | 4.13M | 4.87M | 51.83M |
| Total Current Assets | 16.12M | 14.45M | 12.26M | 11.80M | 55.35M | 119.47M |
| Property, Plant & Equipment | 4.83M | 5.29M | 6.10M | 6.87M | 7.66M | 9.06M |
| Other Intangible Assets | 3.56M | 3.76M | 4.32M | 6.10M | 6.94M | 7.14M |
| Long-Term Accounts Receivable | 12.63M | 13.71M | 16.01M | 18.48M | 20.25M | |
| Other Long-Term Assets | 395.00K | 444.00K | 130.00K | 58.00K | 253.00K | 33.80M |
| Total Assets | 37.53M | 37.66M | 38.82M | 43.31M | 90.46M | 169.47M |
| Accounts Payable | 460.00K | 377.00K | 258.00K | 27.00K | 2.16M | 3.37M |
| Accrued Expenses | 837.00K | 766.00K | 494.00K | 1.66M | 12.76M | 9.12M |
| Current Portion of Long-Term Debt | 188.27M | |||||
| Current Portion of Leases | 1.04M | 975.00K | 1.63M | 1.47M | 1.39M | 1.36M |
| Other Current Liabilities | 2.67M | 2.67M | 2.78M | 3.69M | 30.53M | 50.77M |
| Total Current Liabilities | 5.00M | 4.79M | 5.17M | 6.85M | 46.84M | 252.89M |
| Long-Term Leases | 4.52M | 5.12M | 5.54M | 6.53M | 7.37M | 8.06M |
| Other Long-Term Liabilities | 873.00K | 873.00K | 744.00K | 636.00K | 1.11M | 2.14M |
| Total Liabilities | 10.40M | 10.78M | 11.45M | 14.02M | 55.31M | 263.09M |
| Common Stock | 11.00K | 11.00K | 11.00K | 11.00K | 9.00K | 9.00K |
| Additional Paid-In Capital | 979.26M | 979.26M | 979.18M | 978.92M | 974.50M | 957.73M |
| Retained Earnings | -952.14M | -952.39M | -951.82M | -949.64M | -939.36M | -1.05B |
| Shareholders' Equity | 27.13M | 26.88M | 27.37M | 29.29M | 35.14M | -93.62M |
| Total Liabilities & Equity | 37.53M | 37.66M | 38.82M | 43.31M | 90.46M | 169.47M |
| Total Debt | 5.56M | 6.10M | 7.17M | 8.01M | 8.76M | 197.69M |
| Net Cash (Debt) | 3.63M | 1.39M | -2.12M | -3.68M | 29.31M | -132.79M |
| Net Cash Per Share | 0.31 | 0.12 | -0.18 | -0.35 | 3.13 | -16.68 |
| Filing Date Shares Outstanding | 11.57M | 11.57M | 11.57M | 11.53M | 9.95M | 8.67M |
| Total Common Shares Outstanding | 11.57M | 11.57M | 11.53M | 11.53M | 9.50M | 8.60M |
| Working Capital | 11.12M | 9.66M | 7.09M | 4.94M | 8.51M | -133.42M |
| Book Value Per Share | 2.34 | 2.32 | 2.37 | 2.54 | 3.70 | -10.89 |
| Tangible Book Value | 23.57M | 23.11M | 23.05M | 23.19M | 28.20M | -100.77M |
| Tangible Book Value Per Share | 2.04 | 2.00 | 2.00 | 2.01 | 2.97 | -11.72 |
| Machinery | 2.10M | 2.34M | ||||
| Leasehold Improvements | 49.00K | 80.00K |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -217.00K | -569.00K | -2.18M | -10.28M | 112.00M | -172.41M |
| Depreciation & Amortization | 1.29M | 1.19M | 1.28M | 438.50K | 1.19M | 736.00K |
| Asset Writedown & Restructuring Costs | 101.00K | 176.00K | 1.27M | 483.50K | ||
| Stock-Based Compensation | 57.00K | 75.00K | 264.00K | 1.27M | 11.57M | 18.12M |
| Other Operating Activities | -78.00K | -84.00K | -131.00K | 2.45M | -111.32M | 93.83M |
| Change in Accounts Payable | 110.00K | 119.00K | 231.00K | -2.13M | -1.21M | -1.06M |
| Change in Other Net Operating Assets | 1.84M | 1.54M | 439.00K | -15.31M | -2.88M | 5.65M |
| Operating Cash Flow | 3.12M | 2.42M | 732.00K | -48.14M | -4.08M | -142.69M |
| Capital Expenditures | -34.00K | |||||
| Sale (Purchase) of Intangibles | -355.00K | -2.19M | ||||
| Other Investing Activities | 223.83M | |||||
| Investing Cash Flow | 223.48M | -2.22M | ||||
| Long-Term Debt Repaid | -219.43M | -50.00M | ||||
| Net Debt Issued (Repaid) | -219.43M | -50.00M | ||||
| Issuance of Common Stock | 3.15M | 2.47M | 184.67M | |||
| Other Financing Activities | -1.27M | -5.12M | ||||
| Financing Cash Flow | 3.15M | -235.21M | 129.55M | |||
| Net Cash Flow | 3.12M | 2.42M | 732.00K | -44.99M | -15.80M | -15.36M |
| Free Cash Flow | 3.12M | 2.42M | 732.00K | -48.14M | -4.08M | -142.73M |
| Free Cash Flow Margin | 95.41% | 80.21% | 41.57% | -3,697.46% | -5.83% | -5,547.10% |
| Free Cash Flow Per Share | 0.27 | 0.21 | 0.06 | -4.61 | -0.43 | -17.93 |
| Levered Free Cash Flow | 896.62K | 303.62K | -2.22M | -33.87M | 38.54M | -28.46M |
| Unlevered Free Cash Flow | 896.62K | 303.62K | -2.22M | -33.87M | 38.54M | -28.46M |
| Cash Interest Paid | 13.54M | 25.07M | ||||
| Change in Working Capital | 1.95M | 1.66M | 670.00K | -17.45M | -4.09M | 4.59M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 20.83M | 18.87M | 9.92M | 25.77M | 52.92M | 151.06M |
| Enterprise Value | 17.20M | 18.23M | 12.27M | 23.81M | 148.09M | 241.19M |
| Last Close Price | 1.80 | 1.63 | 0.86 | 2.25 | 5.59 | 17.77 |
| PE Ratio | 0.47 | |||||
| Forward PE | 25.09 | 25.09 | 25.09 | |||
| PS Ratio | 6.37 | 6.24 | 5.63 | 19.79 | 0.76 | 58.71 |
| PB Ratio | 0.77 | 0.70 | 0.36 | 0.88 | 1.51 | -1.61 |
| P/TBV Ratio | 0.88 | 0.82 | 0.43 | 1.11 | 1.88 | |
| P/FCF Ratio | 6.68 | 7.78 | 13.55 | |||
| P/OCF Ratio | 6.68 | 7.78 | 13.55 | |||
| EV/Sales Ratio | 5.26 | 6.03 | 6.97 | 18.28 | 2.12 | 93.74 |
| EV/EBITDA Ratio | 12.49 | |||||
| EV/EBIT Ratio | 13.89 | |||||
| EV/FCF Ratio | 5.51 | 7.52 | 16.76 | |||
| Debt / Equity Ratio | 0.20 | 0.23 | 0.26 | 0.27 | 0.25 | -2.11 |
| Debt / EBITDA Ratio | 0.63 | |||||
| Debt / FCF Ratio | 1.78 | 2.52 | 9.80 | |||
| Net Debt / Equity Ratio | -0.13 | -0.05 | 0.08 | 0.13 | -0.83 | -1.42 |
| Net Debt / EBITDA Ratio | 2.65 | 0.70 | -0.71 | -0.46 | -2.47 | -1.87 |
| Net Debt / FCF Ratio | -1.16 | -0.57 | 2.89 | -0.08 | 7.19 | -0.93 |
| Asset Turnover | 0.09 | 0.08 | 0.04 | 0.02 | 0.54 | 0.01 |
| Quick Ratio | 2.65 | 2.44 | 1.77 | 1.08 | 0.81 | 0.26 |
| Current Ratio | 3.22 | 3.02 | 2.37 | 1.72 | 1.18 | 0.47 |
| Return on Equity (ROE) | -1.08% | -2.41% | -8.16% | -23.90% | ||
| Return on Assets (ROA) | -2.88% | -3.87% | -5.32% | -7.96% | 5.13% | -25.48% |
| Return on Capital Employed (ROCE) | -5.40% | -7.20% | -10.40% | -23.40% | 24.40% | 85.80% |
| Earnings Yield | -1.28% | -3.02% | -21.99% | -39.89% | 211.63% | -114.14% |
| FCF Yield | 14.98% | 12.85% | 7.38% | -186.82% | -7.71% | -94.48% |
| Buyback Yield / Dilution | -0.23% | -0.32% | -10.45% | -11.48% | -17.66% | -44.39% |